Abstract
Lipophilic hormones, including the steroids, thyroid hormones, retinoids, 1,25 dihydroxyvitamin D3, members of the prostaglandin J2 series, and leukotriene B4 represent a diverse group of molecules that can regulate gene expression through a common molecular mechanism. This diverse set of ligands traverse the plasma membrane and bind to ligand-specific intracellular receptors present within the cytosol, perinuclear space, or the nucleus of responsive cell types. Once activated by ligand binding, these intracellular receptors, which are all members of the steroid/nuclear receptor superfamily bind to specific sites on DNA and function as enhancers or repressors of gene transcription [1,2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Chin WW (1989) Hormonal regulation of gene expression. In: DeGroot LJ (ed) Endocrinology. Saunders, Philadelphia, p 6
Manglesdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans, RM (1995) The nuclear receptor super-family: the second decade. Cell 83: 835
Garbe A, Buck J, Hämmerling U (1992) Retinoids are important cofactors in T cell activation. J Exp Med 176: 109
Rigby WFC, Noelle RJ, Krause K, Fanger MW (1985) The effects of 1,25-dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: a cell cycle analysis. J Immunol 135: 2279
Rigby WFC, Denome S, Fanger MW (1987) Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messanger RNA. J Clin Invest 79:1659
Smithson G, Medina K, Ponting I, Kincade PW (1995) Estrogen suppresses stromal cell-dependent lymphopoiesis in culture. J Immunol 155: 3409
Axelrod J, Reisine TD (1984) Stress hormones: their interaction and regulation. Science 244: 452
Fraser R (1992) Biosynthesis of adrenocortical steroids. In: James VHT (ed) The adrenal gland. Raven Press, New York, p 117
Reichlin S (1993) Nueroendocrine-immune interactions. New Engl J Med 329: 1246
Schleimer RP (1993) An overview of glucocorticoid anti-inflammatory actions. Eur J Clin Pharmacol 45: S3
Hench PS (1952) The reversibility of certain rheumatic and nonrheumatic conditions by the use of cortisone or of the pituitary adrenocorticotropic hormone. Ann Intern Med 36: 1
Kass EH, Finland M (1953) Adrenocortical hormones in infection and immunity. Ann Rev Microbiol 7: 361
Sheagren IN (1989) Glucocorticoid action: infectious diseases. In: Schleimer RP, Clamen HN, Oronsky A (eds) Anti-inflammatory steroid action. Academic Press, San Diego, p525
Axelrod L (1989) Side effects of glucocorticoid therapy. In: Schleimer RP, Clamen HN, Oronsky A eds) Anti-inflammatory steroid action. Academic Press, San Diego, p 377
Cupps TR, Fauci AS (1982) Corticosteroid-mediated immunoregulation in man. Immunol Rev 65: 133
Munck A, Guyre PM, Holbrook NJ (1984) Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 5: 25
Cupps TR (1989) Effects of glucocorticoids on lymphocyte function. In: Schleimer RP, Clamen, HN, Oronsky A, (eds) Anti-inflammatory steroid action. Academic Press, San Diego, p132
Lurie MB, Zappadosi P, Dannenberg AMI, Swartz IB (1951) Constitutional factors in resistance to infection: the effect of cortisone on the pathogenesis of tuberculosis. Science 113: 234
Vernon-Roberts B (1969) The effects of steroid hormones on macrophage activity. In: Boume GH, Danielli JF (eds) International Review of Cytology Academic Press, New York, p131
Snyder DS, Unanue ER (1982) Corticosteroids inhibit murine macrophage la expression and interleukin 1 production. J Immunol 129:1803
Rosa MD, Radomski M, Carnuccio R, Moncada S (1990) Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem Biophys Res Comm 172: 1246
Smith RJ, Iden SS (1980) Pharmacological modulation of chemotactic factor-elicited release of granule-associated enzymes from human neutrophils. Effects of prostaglandine, non-steroid anti-inflammatory agents and corticosteroids. Biochem Pharmacol 29:2389
Nelson DH, Wennhold AR, Murray DK (1981) Corticosteroid-induced simultaneous changes in leukocyte phospholipids and superoxide anion production. J Steroid Biochem 14: 321
Kurihara A, Ojima F, Tsurufuji S (1984) Chemotactic factor production by rat polymorphonuclear leukocytes: stimulation with opsonized zymosan particles and inhibition by dexamethasone. Biochem Biophys Res Comm 119: 720
Watanabe M, Yagi M, Omata M, Hirasawa N, Mue S, Tsurufuji S, Ohuchi K (1991) Stimulation of neutrophil adherence to vascular endothelial cells by histamine and thrombin and its inhibition by PAF antagonists and dexamethasone. Br J Pharmacol 102: 239
Schleimer RP (1989) The effects of glucocorticoids on mast cells and basophils. In: Schleimer RP, Clamen HN, Oronsky A (eds) Anti-inflammatory steroid action. Academic Press, San Diego, p 226
Dougherty TF, Berliner DL, Berliner ML (1961) Corticosteroid-tissue interactions. Metab Clin Exp 10: 966
Wyllie AH (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555
Fernandez-Ruiz E, Rebollo A, Nieto MA, Sanz E, Somoza C, Ramirez F, Lopez-Rivas A, Silva A (1989) IL-2 protects T cell hybrids from the cytolytic effect of glucocorticoids. Synergistic effect of IL-2 and dexamethasone in the induction of high-affinity IL-2 receptors. J Immunol 143: 4146
Cohen JJ (1992) Glucocorticoid-induced apoptosis in the thymus. Semin Immunol 4: 363
Zacharchuk CM, Mercep M, Chakraborti P, Simons SSJ, Ashwell JD (1990) Programmed T lymphocyte death: cell activation-and steroid-induced pathways are mutually antagonistic. J Immunol 145: 4037
King LB, Vacchio MS, Dixon K, Hunziker R, Marguiles DH, Ashwell JD (1995) A targeted glucocorticoid receptor antisense transgene increases thymocyte apoptosis and alters thymocyte development. Immunity 3: 647
Garvy BA, King LE, Telford WG, Morford LA, Fraker PJ (1993) Chronic elevation of plasma corticosterone causes reductions in the number of cycling cells of the B lineage in murine bone marrow and induces apoptosis. Immunology 80: 587
Paul WE, Seder RA (1994) Lymphocyte responses and cytokines. Cell 76: 241
Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A (1986) Control of cachectin (tumor necrosis factor) synthesis: mechanism of endotoxin resistance. Science 232: 977
Ray A, Prefontaine KE (1994) Physical association and functional antagonism between the p65 subunit of transcription factor NF-kB and the glucocorticoid receptor. PNAS USA 91: 752
Arya SK, Wong-Staal F, Gallo RC (1984) Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA. J Immunol 133: 273
Daynes RA, Araneo BA (1989) Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukine 2 and interleukin 4. Eur J Immunol 19: 2319
Ramirez F, Fowell DJ, Puklavec M, Simmonds S, Mason D (1996) Glucocorticoids promote a Th2 cytokine response by CD4+ T cells in vitro. J Immunol 156: 2406
de Waal Malefyt RJ, Abrams J, Bennet B, Figdor CG, de Vries JE (1991) Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209
de waal Malefyt R, Figdor CG, Huijbens R, Mohan-Peterson S, Bennett B, Culpepper J, Dang W, Zurawski G, de Vries JE (1993) Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: comparison with IL-4 and modulation by IFNy of IL-10. J Immunol 151: 6370
to Velde AA, Huijbens RJF, Heije K, de Vries JE, Figdor CG (1990) Interleukin-4 (IL-4) inhibits secretion of IL-1ß, tumor necrosis factor a, and IL-6 by human monocytes. Blood 76: 1392
Ayanlarbatuman O, Ferrero AP, Diaz A, Jimenez SA (1991) Regulation of transforming growth factor-b1 gene expression by glucocorticoids in normal human T lymphocytes. J Clin Invest 88: 1574
Errasfa M, Russo-Marie F (1989) A purified lipocortin shares the anti-inflammatory effect of glucocorticosteroids in vivo in mice. Br J Pharmacol 97: 1051
Oursler MJ, Riggs BL, Spelslaerg TC (1993) Glucocorticoid-induced activation of latent transforming growth factor-ß by normal human osteoblast-like cells. Endocrinology 133: 2187
Wright APH, Zilliacus J, McEwan IJ, Dahlman-Wright K, Almof T, Carlstedt-Duke J, Gustafsson J-A (1993) Structure and function of the glucocorticoid receptor. J Steroid Biochem Mol Biol 47: 11
Simons SSJ (1994) Function/activity of specific amino acids in glucocorticoid receptors. Vitam Horm 49: 49
Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM (1987) Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237: 268
Miesfeld RL, Rusconi S, Godowski PJ, Maler BA, Okret S, Wikstrom A-C, Gustafsson A, Yamamoto KR (1986) Genetic complementation of a glucocorticoid receptor deficiency by expression of a cloned receptor cDNA. Cell 46: 389
Pratt WB (1993) The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor. J Biol Chem 268: 21455
Czar MJ, Lyons RH, Welsh MJ, Renoir JM, Pratt WB (1995) Evidence that the FK506binding immunophilin heat shock protein 56 is required for trafficking of the glucocorticoid receptor from the cytoplasm to the nucleus. Mol Endocrinol 9: 1549
Luisi BF, Xu WX, Otwinowski Z, Freedman LP, Yamamoto KR, Sigler PB (1991) Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352: 497
Yang-Yen H-S, Chambard J-C, Sun Y-L, Smeal T, Schmidt TJ, Drouin J, Karin M (1990) Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62: 1205
Jonat C, Rahmsdorf HJ, Park K-K, Cato ACB, Gebel S, Ponta H, Herrlich P (1990) Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62:1189
Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-Kß activity through induction of IKß synthesis. Science 270: 286
Scheinman RI, Cogswell PC, Lofquist AK, Baldwin ASJ (1995) Role of transcriptional activation of IKBa in mediation of Immunosuppression by glucocorticoids. Science 270: 283
Calandra T, Bucala R (1996) Macrophage migration inhibitory factor: a counter-regulator of glucocorticoid action and critical mediator of septic shock. J Inflam 47: 39
Keller-Wood ME, Dallman MF (1984) Corticosteroid inhibition of ACTH secretion. Endocr Rev 5:1
Mandrup-Poulsen T, Nerup J, Reimers JI, Pciot F, Andersen HU, Karlsen A, Bjerre U, Bergholdt R (1995) Cytokines and the endocrine system. I. The immunoendocrine network. Eur. J. Endocrinol 133:660
Munck A, Leung K (1977) Glucocorticoid receptors and mechanism of action. In: Pasqualini JR (ed) Receptors and mechanism of action of steroid hormones. Marcel Dekker, New York, p 311
Ballard PL, Baxter JD, Higgins SJ, Rousseau GG, Tomkins G M (1974) General presence of glucocorticoid receptors in mammalian tissues. Endocrinology 94: 998
Herman JP, Baxter JD, Higgins SJ, Rousseau, GG, Tomkins GM (1989) Localization and regulation of glucocorticoid and mineralocorticoid receptor messenger RNAs in the hippocampal formation of the rat. Mol. Endocrinol 3:1886
Cole TJ, Blendy JA, Schmid W, Strahle U, Schutz G (1993) Expression of the mouse glucocorticoid receptor and its role during development. J Steroid Biochem Mol Biol 47: 49
Bodwell JE, Hu L-M, Hu J.-M, Orti E, Munck A (1993) Glucocorticoid receptors: ATP-dependent cycling and hormone-dependent hyperphosphorylation. J Steroid Biochem Mol Biol 47:31
Hu J-M, Bodwell JE, Munck A (1994) Cell cycle-dependent glucocorticoid receptor phosphorylation and activity. Mol Endocrinol 8: 1709
Hu L-M, Bodwell J, Hu J-M, Orti E, Munck A (1994) Glucocorticoid receptors in ATP-depleted cells. Dephosphorylation, loss of hormone binding, hsp90 dissociation, and ATP-dependent cycling. J Biol Chem 269: 6571
Monder C (1991) Corticosteroids, receptors, and the organ-specific functions of 11β-hydroxysteroid dehydrogenase. FASEB J. 5: 3047
Seckl JR (1993) 11β-hydroxysteroid dehydrogenase isoforms and their implications for blood pressure regulation. Eur J Clin Invest 23:589
Amelung D, Huebner HJ, Roka L, Meyerheim G (1953) Conversion of cortisone to compound F. J Clin Endocrinol Metab 13: 1125
Monder C, White PC (1993) l lβ-Hydroxysteroid dehydrogenase. Vitam Horm 47:187
Whorwood CB, Ricketetts ML, Stewart PM (1994) Regulation of sodium-potassium adenosine triphosphate subunit gene expression by corticosteroids and 11β-hydroxysteroid dehydrogenase activity. Endocrinology 135: 901
Katz AI (1982) Na-K-ATPase: its role in tubular sodium and potassium transport. Am J Physiol 242: F207
Edwards CRW, Stewart PM (1991) The cortisol-cortisone shuttle and the apparent specificity of glucocorticoid and mineralocorticoid receptors. J Steroid Biochem Mol Biol 39: 859
Sheppard K, Funder JW (1987) Mineralocorticoid specificity of renal Type I receptors: in vivo binding studies. Am J Physiol 252: E224
Ulick S, Levine LS, Gunczler P, Zanconato G, Ramirez G, Rauh W, Rosier A, Bradlow HL, New MI (1979) A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab 49: 757
Stewart PM, Corrie JET, Shackleton CHL, Edwards CRW (1988) Syndrome of apparent mineralocorticoid excess. A defect in the cortisol cortisone shuttle. J Clin Invest 82:340
Funder JW, Pearce PT, Smith R, Smith AI (1988) Mineralocorticoid action: target-tissue specificity is enzyme, not receptor, mediated. Science 242: 583
Monder C, Stewart PM, Lakshmi V, Valentino R, Burt D, Edwards CRW (1989) Licorice inhibits corticosteroid 11β-dehydrogenase of rat kidney and liver: In vivo and in vitro studies. Endocrinology 125:1046
Krozowski Z (1992) 11β-hydroxysteroid dehydrogenase and the short-chain alcohol dehydrogenase (SCAD) superfamily. Mol Cell Endocrinol 84:C25
Hales DB, Payne AH (1989) Glucocorticoid-mediated repression of P450scc mRNA and de novo synthesis in cultured Leydig cells. Endocrinology 124: 2099
Payne AH, Sha L (1991) Multiple mechanisms for regulation of 3ß-hydroxysteroid dehydrogenase/Δ5→Δ4-isomerase, 17α-hydroxylase/C17–20 lyase cytochrome P450, and cholesterol side-chain cleavage cytochrome P450 messenger ribonucleic acid levels in primary cultures of mouse Leydig cells. Endocrinology 129: 1429
Phillips DM, Lakshmi V, Monder C (1989) Corticosteroid 11/3-dehydrogenase in rat testis. Endocrinology 125: 209
Monder C, Hardy MP, Blanchard RJ, Blanchard DC (1994) Comparative aspects of 11β-hydroxysteroid dehydrogenase. Testicular 11β-hydroxysteroid dehydrogenase: development of a model for the mediation of Leydig cell function by corticosteroids. Steroids 59: 69
Teelucksingh S, Mackie ADR, Burt D, McIntyre MA, Brett L, Edwards CRW (1990) Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. Lancet 335: 1060
Karstila T, Rechardt L, Honkaniemi J, Gustafsson J-A, Wikstroms A-C, Karppinen A, Pelto-Huikko M (1994) Immunocytochemical localization of glucocorticoid receptor in rat skin. Histochemistry 102: 305
Fuller PJ, Verity K (1990) Colonic sodium potassium adenosine triphosphate subunit gene expression: ontogeny and regulation by adrenocortical steroids. Endocrinology 127: 32
Lakshmi V, Monder C (1988) Purification and characterization of the corticosteroid 1 lß-dehydrogenase component of the rat liver 11β-hydroxysteroid dehydrogenase complex. Endocrinology 123: 2390
Monder C, Lakshmi V (1990) Corticosteroid llβ-dehydrogenase of rat tissues: Immunological studies. Endocrinology 126:2435
Agarwal AK, Monder C, Eckstein B, White PC (1989) Cloning and expression of rat cDNA encoding corticosteroid 11P-dehydrogenase. J Biol Chem 264: 18939
Tannin GM, Agarwal AK, Monder C, New MI, White PC (1991) The human gene for 11β-hydroxysteroid dehydrogenase. J Biol Chem 266: 16653
Yang K, Smith CL, Dales D, Hammond GL, Challis JR (1992) Cloning of an ovine 11 beta-hydroxysteroid dehydrogenase complementary deoxyribonucleic acid: tissue and temporal distribution of its messanger ribonucleic acid during fetal and neonatal development. Endocrinology 131: 2120
Moore CCD, Mellon SH, Murai J, Siiteri PK, Miller WL (1993) Structure and function of the hepatic form of 11β-hydroxysteroid dehydrogenase in the squirrel monkey, an animal model of glucocorticoid resistance. Endocrinology 133: 368
Rajan V, Chapman KE, Lyons V, Jamieson P, Mullins JJ, Edwards C RW, Seckl JR (1995) Cloning, sequencing and tissue-distribution of mouse 1lβ-hydroxysteroid dehydrogenase-1 cDNA. J Steroid Biochem Mol Biol 52: 141
Jamieson PM, Chapman KE, Edwards CRW, Seckl JR (1995) 1lβ-hydroxysteroid dehydrogenase is an exclusive 11β-reductase in primary cultures of rat hepatocytes: effect of physiochemical and hormonal manipulations. Endocrinology 136:4754
Rundle SE, Funder JW, Lakshmi V, Monder C (1989) The intrarenal localization of mineralocorticoid receptors and llβ-dehydrogenase: immunocytochemical studies. Endocrinology 125: 1700
Näray-Fejes-Toth A, Watlington CO, Fejes-Toth G (1991) 11β-hydroxysteroid dehydrogenase activity in the renal target cells of aldosterone. Endocrinology 129:17
Rusvai E, Nâray-Fejes-Toth A (1993) A new isoform of 11β-hydroxysteroid dehydrogenase in aldosterone target cells. J Biol Chem 268: 10717
Stewart PM, Murry BA, Mason JI (1994) Human kidney 11β-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type 1 isoform. J Clin Endocrinol Metab 79: 480
Low SC, Assaad SN, Rajan V, Chapman KE, Edwards CRW, Seckl JR (1993) Regulation of 11β-hydroxysteroid dehydrogenase by sex steroids in vivo: further evidence for the existence of a second dehydrogenase in rat kidney. J Endocrinol 139: 27
Nâray-Fejes-Toth A, Rusvaia E, Denault DL, Germain DLS, Fejes-Toth G (1993) Expression and characterization of a new species of 11β-hydroxysteroid dehydrogenase in Xenopus oocytes: Am J Physiol 265: F896
Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS (1994) Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 105: R1 1
Agarwal AK, Rogerson FM, Mune T, White PC (1995) Analysis of the human gene encoding the kidney isozyme of 11β-hydroxysteroid dehydrogenase. J Steroid Biochem Mol Biol 55: 473
Náray-Fejes-Tóth, A, Fejes-Tóth G (1995) Expression cloning of the aldosterone target cell-specific 11β-hydroxysteroid dehydrogenase from rabbit collecting duct cells. Endocrinology 136: 2579
Cole TJ (1995) Cloning of the mouse 11β-hydroxysteroid dehydrogenase type 2 gene: tissue specific expression and localization in distal convoluted tubules and collecting ducts of the kidney. Endocrinology 136: 4693
Whorwood CR, Ricketts ML, Stewart PM (1994) Epithelial cell localization of type 2 11β-hydroxysteroid dehydrogenase in rat and human colon. Endocrinology 135: 2533
Obeyesekere VR, Ferrari P, Andrews RK, Wilson RC, New MI, Funder JW, Krozowski ZS (1995) The R337C mutation generates a high Km 1lβ-hydroxysteroid dehydrogenase Type II enzyme in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 80: 3381
Stewart PM, Rogerson FM, Mason JI (1995) Type 2 11β-hydroxysteroid dehydrogenase messanger ribonucleic acid and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal adrenal steroidogenesis. J Clin Endocrinol Metab 80: 885
Krozowski Z, Maguire JA, Stein-Oakley AN, Dowling J, Smith RE, Andrews RK (1995) Immunohistochemical localization of the 11β-hydroxysteroid dehydrogenase Type II in human kidney and placenta. J Clin Endocrinol Metab 80: 2203
Langlois DA, Matthews SG, Yu M, Yang K (1995) Differential expression of llβ-hydroxysteroid dehydrogenase 1 and 2 in the developing ovine fetal liver and kidney. J Endocrinol 147: 405
Brown RW, Diaz R, Robson A, Kotelevstev YV, Mullins JJ, Kaufman MH, Seckl JR (1996) The ontogeny of 11β-hydroxysteroid dehydrogenase Type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development. Endocrinology 137: 794
Murphy BEP (1979) Cortisol and cortisone in human fetal development. J Steroid Biochem 11: 509
Murphy BEP (1981) Ontogeny of cortisol-cortisone interconversion in human tissues: a role for cortisone in human fetal development. J Steroid Biochem 14: 811
Benediktsson R, Lindsay RS, Noble J, Seckl JR, Edwards CR W (1993) Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 341: 339
Lindsay RS, Noble JM, Edwards CRW, Seckl JR (1994) Maternal carbenoxolone treatment reduces birth weight in the rat. J Endocrinol 140 (Suppl): 18
Andersson S (1995) 17β-hydroxysteroid dehydrogenase: isozymes and mutations. J Endocrinol 146:197
Labrie F, Simard J, Luu-The V, Belanger A, Pelletier G (1992) Structure, function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues. J Steroid Biochem Mol Biol 43: 805
Walker BR, Moisan, MP (1992) Multiple isoforms of the cortisol-cortisone shuttle. J Endocrinol 133: 1
Whorwood CB, Franklyn JA, Sheppard MC, Stewart PM (1992) Tissue localization of 11β-hydroxysteroid dehydrogenase and its relationship to the glucocorticoid receptor. J Steroid Biochem Mol Biol 41: 21
Gomez-Sanchez EP, Cox D, Foecking M, Ganjam V, Gomez-Sanchez CE (1996) llβ-hydroxysteroid dehydrogenase of the choriocarcinoma cell line JEG-3 and their inhibition by glycyrrhetinic acid and other natural substances. Steroids 61: 110
Dougherty TF, Berliner ML, Berliner DL (1960) 1lβ-Hydroxy dehydrogenase system activity in thymi of mice following prolonged cortisol treatment. Endocrinology 66: 550
Marandici A, Monder C (1993) Inhibition by glycyrrhetinic acid of rat tissue 11β-hydroxysteroid dehydrogenase in vivo. Steroids 58: 153
Hennebold JD, Ryu SY, Mu H-H, Galbraith A, Daynes RA (1996) l lβ-Hydroxysteroid dehydrogenase modulation of glucocorticoid activities in lymphoid organs. Am J Physiol 270: R1296
Daynes RA, Araneo BA, Dowell TA, Huang K, Dudley D (1990) Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J Exp Med 171: 979
Deckx R, De Moor P (1966) Study of the 11β-hydroxysteroid dehydrogenase in vitro. I. Biochemical characterization in spleen homogenate. Pflugers Arch 289: 59
Agarwal AK, Mune T, Monder C, White PC (1994) NAD+ dependent isoform of 11β hydroxysteroid dehydrogenase. J Biol Chem 269: 25959.
Hennebold JD, Mu H-H, Poynter ME, Chen X-P, Daynes RA (1997) Active catabolism of glucocorticoids by 11β-hydroxysteroid dehydrogenase in vivo is a necessary requirement for natural resistance to infection with Listeria monocytogenes. Int Immunol 9: 105
Brattsand R, Thalen A, Roemke K, Kallstrom L, Gruvstad E (1982) Development of new glucocorticoids with a very high ratio between topical and systemic activities. Eur J Resp Dis 63: 62
Boockvar KS, Granger DL, Poston RM, Maybodi M, Washington M K, Hibbs Jr, JB, Kurlander RL (1994) Nitric oxide produced during murine Listeriosis is protective. Infect Immun 62: 1089
Kelly JP, Bancroft GJ (1996) Administration of interleukin-10 abolishes innate resistance to Listeria monocytogenes. Eur J Immunol 26: 356
Daynes RA, Araneo BA, (1992) Prevention and reversal of some age-associated changes in immunologic responses by supplemental dehydroepiandrosterone sulfate therapy. Aging Immunol Infect Dis 3: 135
Daynes RA, Araneo BA, Ershler WB, Maloney C, Li G-Z, Ryu S-Y (1993) Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J Immunol 150: 5219
Clerici M, Shearer GM (1994) The Thl-Th2 hypothesis of HIV infection: new insights. Immunol Today 15: 575
Araneo BA, Shelby J, Li G-Z, Ku W, Daynes RA (1993) Administration of dehydroepiandrosterone to burned mice preserves normal immunologic competence. Arch Surgery 128: 318
Vaugham VM, Becker RA, Allen JP, Goodwin CV, Pruitt BA, Mason AD (1982) Cortisol and corticotropin in burned patients. J Trauma 22: 263
Montanini VM, Simoni M, Chiossi G, Baraghini GF, Verlardo A, Barald E, Marrama P (1988) Age-related changes in plasma dehydroepiandrosterone sulphate, cortisol, testosterone and free testosterone circadian rhythms in adult men. Horm Res 29: 1
Clerici M, Bevilacqua M, Vago T, Villa ML, Shearer GM, Norbiato G (1994) An immunoendocrinological hypothesis of HIV infection. Lancet 373: 1552
Dodt C, Theine KJ, Uthgenannt D, Born J, Fehm HL (1994) Basal secretory activity of the hypothalamo-pituitary-adrenocortical axis is enhanced in healthy elderly. An assessment during undisturbed night-time sleep. Eur J Endocrinol 131: 443
Yau JLW, Olsson T, Morris RGM, Meaney MJ, Seckl JR (1995) Glucocorticoids, hippocampal corticosteroid receptor gene expression and antidepressant treatment: relationship with spatial learning in young and aged rats. Neuroscience 66: 571
Chorinchath BB, Kong L-Y, Mao L, McCallum RE (1996) Age-associated differences in TNF-a and nitric oxide production in endotoxic mice. J Immunol 156: 1525
Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, Bucala R (1995) MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377: 68
Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, Manogue KR, Cerami A, Bucala R (1993) MIF is a pituitarty-derived cytokine that potentiates lethal endotoxaemia. Nature 365: 756
Bernhagen J, Bacher M, Calandra T, Metz CN, Doty SB, Donnelly T, Bucala R (1996) An essential role for macrophage migration inhibitory factor in the tuberculine delayed-type hypersensitivity reaction. J Exp Med 183: 277
Bernhagen J, Mitchell RA, Calandra T, Voelter W, Cerami A, Bucala R (1994) Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor ( MIF ). Biochemistry 33: 14144
Calandra T, Bernhagen J, Mitchell RA, Bucala R (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179: 1895
Shimuzu T, Ohkawara A, Nishihira J, Sakamoto W (1996) Identification of macrophage migration inhibitory factor ( MIF) in human skin and its immunohistochemical localization. FEBS Lett 381: 199
Weiser WY, Temple PA, Witek-Giannotti JS, Remold HG, Clark S C, David JR (1989) Molecular cloning of a cDNA encoding a human macrophage inhibitory factor. Proc Natl Sci Counc Repub China [B] 86: 7522
Mitchell R, Bacher M, Bernhagen J, Pushkarskaya T, Seldin MF, Bucala R (1995) Cloning and characterization of the gene for mouse macrophage migration inhibitory factor ( MIF ). J Immunol 154: 3863
Meikle WA, Daynes RA, Araneo BA (1991) Adrenal androgen secretion and biologic effects. In: Nelson DH (ed) Endocrinology and metabolism clinics of north america. New aspects of adrenal cortical disease. Saunders, Philadelphia, p 381
Orentreich N, Brind JL, Rizer RL, Vogelman JH (1984) Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59: 551
Spencer NFL, Norton SD, Harrison LL, Li G-L, Daynes RA (1995) Dysregulation of IL-10 production with aging: possible linkage to the age-associated decline in DHEA and its sulfated derivative. Exp Gerontol 31: 393
Hennebold JD, Poynter ME, Daynes RA (1995) DHEA and immune function: activities and mechanism of action. Semin Reprod Endocrinol 13: 257
Frenkel RA, Slaughter CA, Orth K, Moomaw CR, Hicks SH, Snyder JM, Bennett M, Prough RA, Putnam RS, Milewich L (1990) Peroxisome proliferation and induction of peroxisomal enzymes in mouse and rat liver by dehydroepiandrosterone feeding. J Steroid Biochem 35: 333
Peters JM, Zhou YC, Ram PA, Lee SST, Gonzalez FJ, Waxman DJ (1996) Peroxisome proliferator-activated receptor a required for gene induction by dehydroepiandrosterone-3ß-sulfate. Mol Pharmacol 50: 67–74
van der Bosch H, Schutgens RBH, Wanders RJA, Tager JM (1992) Biochemistry of peroxisomes. Annu Rev Biochem 61: 157
Beier K, Völkl A, Fahimi HD (1993) The impact of aging on enzyme proteins of rat liver peroxisomes: quantitative analysis by immunoblotting and immunoelectron microscopy. Virchows Arch [B] 63: 139
Bunker VW (1992) Free radicals, antioxidants and ageing. Med Lab Sci 42: 299
Harman D (1956) Aging: A theory based on free radical and radiation chemistry. J Gerontol 11: 298
Greenwald RA, Moy WW (1980) Effect of oxygen-free radicals on hyaluronic acid. Arthritis Rheum 23: 455
Wolf SP, Dean RT (1986) Fragmentation of proteins by free radicals and its effect on their susceptibility to enzymatic hydrolysis. Biochem J 234: 399
Stadtman ER (1992) Protein oxidation and aging. Science 257: 1220
Schreck R, Rieber P, Baeuerle PA (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappaB transcription factor and HIV-1. EMBO J 10: 2247
Kopp EB, Ghosh S (1995) NF-KB and Rel proteins in innate immunity. Adv Immunol 58: 1
Lemberger T, Staels B, Saladin R, Desvergne B, Auwerx J, Wahli W (1994) Regulation of the peroxisome proliferator-activated receptor a gene by glucocorticoids. J Biol Chem 269: 24527
Lemberger T, Saladin R, Vazquez M, Assimacopoulos F, Staels B, Desvergne B, Wahli W, Auwerx J (1996) Expression of the peroxisome proliferator-activated receptor a gene is stimulated by stress and follows a diurnal rhythm. J Biol Chem 271: 1764
Steineger HH, Sorensen HN, Tugwood JD, Skrede S, Spydevold 0, Gautvik KM (1994) Dexamethasone and insulin demonstrate marked and opposite regulation of the steady-state mRNA level of the peroxisomal proliferator-activated receptor (PPAR) in hepatic cells: hormonal modulation of fatty-acid-induced transcription. Eur J Biochem 225: 967
Devchand PR, Keller H, Peters JM, Vazquez M, Gonzalez FJ, Wahli W (1996) The PPARα-leukotriene B4 pathway to inflammation control. Nature 384: 39
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag London Limited
About this chapter
Cite this chapter
Hennebold, J.D., Daynes, R.A. (1997). Microenvironmental control of glucocorticoid functions in immune regulation. In: Rook, G.A.W., Lightman, S. (eds) Steroid Hormones and the T-Cell Cytokine Profile. Springer, London. https://doi.org/10.1007/978-1-4471-0931-0_5
Download citation
DOI: https://doi.org/10.1007/978-1-4471-0931-0_5
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1238-9
Online ISBN: 978-1-4471-0931-0
eBook Packages: Springer Book Archive